View By:Year | Company | Conditions | Therapeutic Areas | Drug Names
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale
in the United States. Drug information typically includes the drug name, approval status, indication of use, and
clinical trial results.
Review descriptions for our medical therapeutic area list to help
assist in your search.
Join our Drug Research Updates group on LinkedIn!
Aveed (testosterone undecanoate) injection; Endo Pharmaceuticals;
For the treatmenr of hypogonadism, Approved March 2014
Farxiga (dapagliflozin); Bristol-Myers Squibb;
For the treatment of type II diabetes, January of 2014
Myalept (metreleptin for injection); Bristol-Myers Squibb;
For the treatment of congenital or acquired generalized lipodystrophy, Approved February of 2014
Northera (droxidopa); Chelsea Therapeutics;
For the treatment of neurogenic orthostatic hypotension, Approved February 2014
Tivorbex (indomethacin); Iroko Pharmaceuticals;
For the treatment of acute pain, Approved February of 2014
Vimizim (elosulfase alfa); BioMarin;
For the treatment of Mucopolysaccharidosis type IVA, Approved February 2014
Imbruvica (ibrutinib); Pharmacyclics;
For the treatment of chronic lymphocytic leukemia, Approved February 2014
Hetlioz (tasimelteon); Vanda Pharmaceuticals;
For the treatment of non-24-hour sleep-wake disorder in the totally blind, January 2014